Please use this identifier to cite or link to this item:
|Title:||Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients||Austin Authors:||Lim, Hui Yin;Grigg, Andrew P||Affiliation:||Department of Clinical Haematology, Austin Health||Issue Date:||Mar-2016||Publication information:||Internal Medicine Journal 2016; 46(3): 347-351||Abstract:||There is a paucity of evidence supporting the necessity or duration of Pneumocystis jirovecii and antiviral prophylaxis as well as revaccination following autologous stem cell transplant (ASCT). A survey aimed at evaluating these policies was distributed to 34 ASCT centres across Australasia. The 26 survey respondents demonstrated significant heterogeneity in their infection prophylaxis and revaccination strategy post-transplant despite the availability of consensual guidelines||URI:||http://ahro.austin.org.au/austinjspui/handle/1/13748||DOI:||10.1111/imj.12992||ORCID:||0000-0003-2455-3155||PubMed URL:||https://pubmed.ncbi.nlm.nih.gov/26968596||Type:||Journal Article||Subjects:||Immunization, Secondary
Hematopoietic Stem Cell Transplantation
|Type of Clinical Study or Trial:||Survey|
|Appears in Collections:||Journal articles|
Show full item record
checked on Nov 25, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.